Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (731-740 of 1,132) with videos related to

Pageof 114
Sort By:
Bulletin of Experimental Biology and Medicine|March 21, 2007
Modulatory action of combined treatment with antibodies against S100 protein and low doses of this protein on membrane effects of quinineO I Epstein, M B Shtark, V V Andrianov, et al.
Bulletin of Experimental Biology and Medicine|December 23, 2009
Expression of S100B and S100A6 genes during long-term posttetanic potentiation in the hippocampusO O Sokolova, M B Shtark, P D Lisachev, et al.
Urology|January 19, 2020
Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate CancerMitchell M Huang, Katarzyna J Macura, Patricia Landis, et al.
The Canadian Journal of Urology|October 4, 2015
Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsySeyed Saeid Dianat, H Ballentine Carter, Edward M Schaeffer, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis]K K Ganina, Yu L Dugina, E S Zhavbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate CancerJeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of potentiated antibodies to cyclophosphamide on the development of tumors and effectiveness of cytostatic therapy under experimental conditionsE N Amosova, E P Zueva, T G Razina, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
In vitro effects of bipathic treatment with antibodies in ultralow doses during long-term post-tetanic potentiationO I Epstein, N A Beregovoi, T M Pankova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Membranotropic effects of antibodies to S100 protein in ultralow dosesV V Andrianov, Kh L Gainutdinov, T Kh Gainutdinova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Impaza and sildenafil: comparison of clinical effectiveness in patients with erectile dysfunctionV I Petrov, A S Vekel'yan, A V Martyushev, et al.
Pageof 114

Showing results (731-740 of 1,132) with videos related to

Sort By:
Pageof 114
Bulletin of Experimental Biology and Medicine|March 21, 2007
Modulatory action of combined treatment with antibodies against S100 protein and low doses of this protein on membrane effects of quinineO I Epstein, M B Shtark, V V Andrianov, et al.
Bulletin of Experimental Biology and Medicine|December 23, 2009
Expression of S100B and S100A6 genes during long-term posttetanic potentiation in the hippocampusO O Sokolova, M B Shtark, P D Lisachev, et al.
Urology|January 19, 2020
Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate CancerMitchell M Huang, Katarzyna J Macura, Patricia Landis, et al.
The Canadian Journal of Urology|October 4, 2015
Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsySeyed Saeid Dianat, H Ballentine Carter, Edward M Schaeffer, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis]K K Ganina, Yu L Dugina, E S Zhavbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate CancerJeffrey J Tosoian, Mufaddal Mamawala, Jonathan I Epstein, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of potentiated antibodies to cyclophosphamide on the development of tumors and effectiveness of cytostatic therapy under experimental conditionsE N Amosova, E P Zueva, T G Razina, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
In vitro effects of bipathic treatment with antibodies in ultralow doses during long-term post-tetanic potentiationO I Epstein, N A Beregovoi, T M Pankova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Membranotropic effects of antibodies to S100 protein in ultralow dosesV V Andrianov, Kh L Gainutdinov, T Kh Gainutdinova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Impaza and sildenafil: comparison of clinical effectiveness in patients with erectile dysfunctionV I Petrov, A S Vekel'yan, A V Martyushev, et al.
Pageof 114